Zimmer Biomet Holdings, a US-based medical device company: Introduction + Website Domain Summary

Zimmer Biomet Holdings is an American medical device manufacturer founded in 2001 (its origins can be traced back to 1927), headquartered in Warsaw, Indiana. The current CEO is Ivan Tornos, and the company employs approximately 17,000 people. The company's main products include orthopedic reconstruction, sports medicine, limb trauma, and digital surgical robots. In 2025, it ranked 483rd on the Fortune 500 list with revenue of $7.679 billion.

In 2015, Zimmer Holdings acquired Biomet for $13.4 billion, renaming it Zimmer Biomet, thus establishing itself as a global orthopedic giant. In 2022, it spun off its spine and dental businesses to form the independent publicly traded company ZimVie, focusing on its core orthopedic field. In 2025, it completed a board reorganization and entered the foot and ankle orthopedic market through the acquisition of Paragon 28. Its product line includes the ROSA knee/spine surgical robot system, the Oxford® cementless knee system, and the Persona® revision solution. The ROSA system has received FDA approval for brain, spine, and knee surgeries.

Founded in Indiana, USA in 1927, Zimmer Biomet Corporation primarily manufactures orthopedic medical devices. In 1972, it was acquired by Bristol-Myers Squibb, becoming its orthopedic business unit. It officially entered the Chinese market in 1994. After being spun off from Bristol-Myers Squibb in 2001, it became an independent company and simultaneously listed on the New York Stock Exchange. In 2015, Zimmer Biomet acquired its competitor, Zimmer Biomet Corporation, and officially changed its name to Zimmer Biomet Holdings.

Company Name: Zimmer Biomet Holdings.

Official Domain: zimmerbiomet.com.

Domain Created: April 24, 2014.

Country: USA.

Headquarters: Warsaw, USA.

Founded: 1927.